Skip to main content

Advertisement

Log in

Local Inflammation Alters MMP-2 and MMP-9 Gelatinase Expression Associated with the Severity of Nifedipine-Induced Gingival Overgrowth: a Rat Model Study

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Nifedipine-induced gingival overgrowth (NIGO) is characterized by cell proliferation and extracellular matrix (ECM) component accumulation in gingival connective tissues, with varying degrees of inflammation and fibrosis. Impaired collagen and ECM homeostasis may be among the underlying molecular mechanisms that lead to the fibrotic changes that occur in drug-induced gingival overgrowth (DIGO). Because matrix metalloproteinases (MMPs) play vital roles in regulating collagen and ECM metabolism, many studies have been performed to reveal the relationship between MMPs and DIGO. It is thought that the gelatinases MMP-2 and MMP-9, both type IV collagenases, are involved in the development of tissue inflammation and organ fibrosis. However, the few studies regarding gelatinase expression in DIGO are controversial. Recent studies have demonstrated the inhibitory effect of cyclosporine A (CsA) on gelatinase expression and/or activity; however, similar changes have yet to be detected in Nif-treated gingival tissues. In this study, we verified that Nif treatment could lead to gingival overgrowth in rats and that gingival inflammation played a pro-proliferative role in NIGO development. Additionally, we examined the temporal expression of gelatinases on days 0, 7, 14, 21, 30, and 40 during NIGO development. The aim was to investigate whether MMP-2 and MMP-9 played significant roles in regulating NIGO development and progression. MMP-2 gene expression was not altered by Nif treatment alone but was significantly inhibited by Nif treatment for 30 days in the presence of local inflammation. However, no significant alterations in MMP-2 protein expression were detected in the Nif-treated gingival tissue, regardless of the presence or absence of local inflammation. Moreover, Nif treatment could lead to transient and significant increases in MMP-9 gene and protein expression levels in the presence of local inflammation. In particular, active MMP-9 expression increased significantly in the gingival tissue that received the combined effect of Nif and ligation treatment; besides, a temporal, but not significant, change was also observed in the gingival tissue that received Nif treatment alone. Taken together, these results provided evidence that temporal changes in MMP-2 and MMP-9 expression occurred during NIGO development. Nif treatment accompanied by local inflammation regulated MMP-2 and MMP-9 expression, primarily MMP-9, which was most likely associated with NIGO severity. Thus, MMP-9 is a potential contributing factor in the process of NIGO development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Livada, R., and J. Shiloah. 2014. Calcium channel blocker-induced gingival enlargement. Journal of Human Hypertension 28(1): 10–14.

    Article  CAS  PubMed  Google Scholar 

  2. Barak, S., I.S. Engelberg, and J. Hiss. 1987. Gingival hyperplasia caused by nifedipine. Histopathologic findings. Journal of Periodontology 58(9): 639–642.

    Article  CAS  PubMed  Google Scholar 

  3. Slavin, J., and J. Taylor. 1987. Cyclosporin, nifedipine, and gingival hyperplasia. Lancet 2(8561): 739.

    Article  CAS  PubMed  Google Scholar 

  4. Fattore, L., M. Stablein, G. Bredfeldt, et al. 1991. Gingival hyperplasia: a side effect of nifedipine and diltiazem. Special care in dentistry: official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped. The Journal of the American Society for Geriatric Dentistry 11(3): 107–109.

    CAS  Google Scholar 

  5. Barclay, S., J.M. Thomason, J.R. Idle, et al. 1992. The incidence and severity of nifedipine-induced gingival overgrowth. Journal of Clinical Periodontology 19(5): 311–314.

    Article  CAS  PubMed  Google Scholar 

  6. Ramon, Y., S. Behar, Y. Kishon, et al. 1984. Gingival hyperplasia caused by nifedipine-a preliminary report. International Journal of Cardiology 5(2): 195–206.

    Article  CAS  PubMed  Google Scholar 

  7. Nishikawa, S., T. Nagata, I. Morisaki, et al. 1996. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. Journal of Periodontology 67(5): 463–471.

    Article  CAS  PubMed  Google Scholar 

  8. Seymour, R.A., J.S. Ellis, and J.M. Thomason. 2000. Risk factors for drug-induced gingival overgrowth. Journal of Clinical Periodontology 27(4): 217–223.

    Article  CAS  PubMed  Google Scholar 

  9. Correa, J.D., C.M. Queiroz-Junior, J.E. Costa, et al. 2011. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN Dentistry 2011: 497850.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Miranda, J., L. Brunet, P. Roset, et al. 2001. Prevalence and risk of gingival enlargement in patients treated with nifedipine. Journal of Periodontology 72(5): 605–611.

    Article  CAS  PubMed  Google Scholar 

  11. Subramani, T., V. Rathnavelu, and N.B. Alitheen. 2013. The possible potential therapeutic targets for drug induced gingival overgrowth. Mediators of Inflammation 2013: 639468.

    PubMed Central  PubMed  Google Scholar 

  12. Guncu, G.N., F. Caglayan, A. Dincel, et al. 2007. Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth. Australian Dental Journal 52(4): 295–299.

    Article  CAS  PubMed  Google Scholar 

  13. Ilgenli, T., G. Atilla, and H. Baylas. 1999. Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. Journal of Periodontology 70(9): 967–972.

    Article  CAS  PubMed  Google Scholar 

  14. Meikle, M.C., S.J. Atkinson, R.V. Ward, et al. 1989. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases. Journal of Periodontal Research 24(3): 207–213.

    Article  CAS  PubMed  Google Scholar 

  15. Johanson, M., X.R. Zhao, G. Huynh-Ba, et al. 2013. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and inflammation in cyclosporine A-induced gingival enlargement: a pilot in vitro study using a three-dimensional model of the human oral mucosa. Journal of Periodontology 84(5): 634–640.

    Article  CAS  PubMed  Google Scholar 

  16. Dannewitz, B., C. Edrich, P. Tomakidi, et al. 2006. Elevated gene expression of MMP-1, MMP-10, and TIMP-1 reveal changes of molecules involved in turn-over of extracellular matrix in cyclosporine-induced gingival overgrowth. Cell and Tissue Research 325(3): 513–522.

    Article  CAS  PubMed  Google Scholar 

  17. Lu, H.K., C.C. Tseng, Y.H. Lee, et al. 2010. Flutamide inhibits nifedipine-and interleukin-1 beta-induced collagen overproduction in gingival fibroblasts. Journal of Periodontal Research 45(4): 451–457.

    CAS  PubMed  Google Scholar 

  18. Kanno, C.M., J.A. Oliveira, J.F. Garcia, et al. 2008. Effects of cyclosporin, phenytoin, and nifedipine on the synthesis and degradation of gingival collagen in tufted capuchin monkeys (Cebus apella): histochemical and MMP-1 and -2 and collagen I gene expression analyses. Journal of Periodontology 79(1): 114–122.

    Article  CAS  PubMed  Google Scholar 

  19. Sakagami, G., E. Sato, Y. Sugita, et al. 2006. Effects of nifedipine and interleukin-1alpha on the expression of collagen, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts. Journal of Periodontal Research 41(4): 266–272.

    Article  CAS  PubMed  Google Scholar 

  20. Kuo, P.J., H.P. Tu, Y.T. Chin, et al. 2012. Cyclosporine-A inhibits MMP-2 and -9 activities in the presence of Porphyromonas gingivalis lipopolysaccharide: an experiment in human gingival fibroblast and U937 macrophage co-culture. Journal of Periodontal Research 47(4): 431–438.

    Article  CAS  PubMed  Google Scholar 

  21. Sume, S.S., A. Kantarci, A. Lee, et al. 2010. Epithelial to mesenchymal transition in gingival overgrowth. The American Journal of Pathology 177(1): 208–218.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Subramani, T., V. Rathnavelu, S.K. Yeap, et al. 2013. Influence of mast cells in drug-induced gingival overgrowth. Mediators of Inflammation 2013: 275172.

    PubMed Central  PubMed  Google Scholar 

  23. Page-McCaw, A., A.J. Ewald, and Z. Werb. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nature Reviews Molecular Cell Biology 8(3): 221–233.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Nissinen, L., and V.M. Kahari. 2014. Matrix metalloproteinases in inflammation. Biochimica et Biophysica Acta-General Subjects 1840(8): 2571–2580.

    Article  CAS  Google Scholar 

  25. Serra, R., A.G. Al-Saidi, N. Angelov, et al. 2010. Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin. J Inflamm-Lond 7.

  26. Kato, T., N. Okahashi, T. Ohno, et al. 2006. Effect of phenytoin on collagen accumulation by human gingival fibroblasts exposed to TNF-alpha in vitro. Oral Diseases 12(2): 156–162.

    Article  CAS  PubMed  Google Scholar 

  27. Corbel, M., C. Belleguic, E. Boichot, et al. 2002. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biology and Toxicology 18(1): 51–61.

    Article  CAS  PubMed  Google Scholar 

  28. Yaguchi, T., Y. Fukuda, M. Ishizaki, et al. 1998. Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis. Pathology International 48(12): 954–963.

    Article  CAS  PubMed  Google Scholar 

  29. Salo, T., M. Makela, M. Kylmaniemi, et al. 1994. Expression of matrix metalloproteinase-2 and metalloproteinase-9 during early human wound-healing. Laboratory Investigation 70(2): 176–182.

    CAS  PubMed  Google Scholar 

  30. Fu, E., S. Nieh, H.L. Chang, et al. 1996. Cyclosporin A-induced gingival overgrowth in rats: macroscopic and microscopic observations. The International Journal of Periodontics & Restorative Dentistry 16(3): 278–291.

    CAS  Google Scholar 

  31. Fernandes, M.I., E.J. Gaio, C. Susin, et al. 2010. Effect of nifedipine on gingival enlargement and periodontal breakdown in ligature-induced periodontitis in rats. Archives of Oral Biology 55(7): 523–529.

    Article  CAS  PubMed  Google Scholar 

  32. Guo, J., W. Wang, L. Yao, et al. 2008. Local inflammation exacerbates cyclosporine a-induced gingival overgrowth in rats. Inflammation 31(6): 399–407.

    Article  CAS  PubMed  Google Scholar 

  33. Fu, E., S. Nieh, C.T. Hsiao, et al. 1998. Nifedipine-induced gingival overgrowth in rats: brief review and experimental study. Journal of Periodontology 69(7): 765–771.

    Article  CAS  PubMed  Google Scholar 

  34. Morisaki, I., K. Kato, J.P. Loyola-Rodriguez, et al. 1993. Nifedipine-induced gingival overgrowth in the presence or absence of gingival inflammation in rats. Journal of Periodontal Research 28(6 Pt 1): 396–403.

    CAS  PubMed  Google Scholar 

  35. Fu, E., S. Nieh, and U.M. Wikesjo. 1997. The effect of plaque retention on cyclosporine-induced gingival overgrowth in rats. Journal of Periodontology 68(1): 92–98.

    Article  CAS  PubMed  Google Scholar 

  36. Chiu, H.C., Y.T. Lu, Y.T. Chin, et al. 2009. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva. Journal of Periodontal Research 44(3): 338–347.

    Article  CAS  PubMed  Google Scholar 

  37. Fu, M. M., E. Fu, P. J. Kuo, et al. 2014. Gelatinases and Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) are Associated With Cyclosporine-A Induced Attenuation of Periodontal Degradation in Rats. Journal of Periodontology: 1–20.

  38. Kurzepa, J., J. Kurzepa, P. Golab, et al. 2014. The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke. The International Journal of Neuroscience 124(10): 707–716.

    Article  CAS  PubMed  Google Scholar 

  39. Kubota, T., M. Itagaki, C. Hoshino, et al. 2008. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. Journal of Periodontology 79(1): 166–173.

    Article  CAS  PubMed  Google Scholar 

  40. Ejeil, A.L., S. Igondjo-Tchen, S. Ghornrasseni, et al. 2003. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human Gingiva. Journal of Periodontology 74(2): 188–195.

    Article  CAS  PubMed  Google Scholar 

  41. Goncalves, L.D., G. Oliveira, P.A. Hurtado, et al. 2008. Expression of metalloproteinases and their tissue inhibitors in inflamed gingival biopsies. Journal of Periodontal Research 43(5): 570–577.

    CAS  PubMed  Google Scholar 

  42. Lorencini, M., J.A. Silva, C.L. de la Hoz, et al. 2009. Changes in MMPs and inflammatory cells in experimental gingivitis. Histology and Histopathology 24(2): 157–166.

    CAS  PubMed  Google Scholar 

  43. Kantarci, A., Z. Nseir, Y.S. Kim, et al. 2011. Loss of basement membrane integrity in human gingival overgrowth. Journal of Dental Research 90(7): 887–893.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Tsai, C.H., Y.J. Chen, F.M. Huang, et al. 2005. The upregulation of matrix metalloproteinase-9 in inflamed human dental pulps. Journal of Endodontics 31(12): 860–862.

    Article  PubMed  Google Scholar 

  45. Seguier, S., B. Gogly, A. Bodineau, et al. 2001. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? Journal of Periodontology 72(10): 1398–1406.

    Article  CAS  PubMed  Google Scholar 

  46. Smith, P.C., V.C. Munoz, L. Collados, et al. 2004. In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epithelium in human periodontal disease. Journal of Periodontal Research 39(2): 87–92.

    Article  CAS  PubMed  Google Scholar 

  47. Mohan, R., S.K. Chintala, J.C. Jung, et al. 2002. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. The Journal of Biological Chemistry 277(3): 2065–2072.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are very grateful for the assistance from Yi Eve Sun’s Lab at the Translational Center for Stem Cell Research, Tongji Hospital, Tongji University School of Medicine. We thank Prof. Yi Eve Sun for her guidance in our research work and Dr. Bo Jing for her technical support. This work was supported by National Natural Science Foundation of China (No.81070825, 81170951).

Conflicts of Interest

The authors deny any conflicts of interest related to this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shou-Liang Zhao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, WL., Wu, CH., Yang, J. et al. Local Inflammation Alters MMP-2 and MMP-9 Gelatinase Expression Associated with the Severity of Nifedipine-Induced Gingival Overgrowth: a Rat Model Study. Inflammation 38, 1517–1528 (2015). https://doi.org/10.1007/s10753-015-0126-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-015-0126-0

KEY WORDS

Navigation